About ORCA-3: A Clinical Study of Cytisinicline as a New Treatment Option to Help Adults Quit Smoking
The ORCA-3 study is being conducted to learn more about the effectiveness and safety of an oral medicine, cytisinicline, in combination with behavioral support in people trying to quit cigarette smoking.
![Precision Clinical Research](https://pcrflorida.com/wp-content/uploads/blank.png)
Precision Clinical ResearchJune 12, 2022